Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThe Mission Group Regulatory News (TMG)

Share Price Information for The Mission Group (TMG)

Share Price is delayed by 15 minutes
Get Live Data
18.00    0.00 (0.00%)
Bid:
17.00
Ask:
19.00
Spread: 2.00 (11.765%)
Market Cap: £16.31m
TMG Live PriceLast checked at - London Stock Exchange

Intraday The Mission Group Share Chart

Directorate Change

17 Dec 2021 07:00

RNS Number : 9380V
Mission Group PLC (The)
17 December 2021
Β 

17 December 2021

THEΒ MISSION GROUP plc

Β 

("MISSION", "the Group")Β 

Β 

Appointment of Non-Executive Director

TheΒ MISSIONΒ Group plcΒ (AIM: TMG), creator ofΒ Work ThatΒ CountsΒ comprising a network of 16 Agencies delivering real, sustainable growth for its Clients, is pleased to announce that is has appointed Dr Eliza Filby as a Non-Executive Director, effective 1 January 2022.

Dr Eliza Filby is a 'Generational Intelligence' expert with a longstanding career in helping businesses understand generational shifts within politics, society and the workplace.Β Her experience involves consulting with a large range of companies and organisations including Warner Brothers, HSBC, the Ministry of Defence and the Royal Household.

Β 

Dr Filby will replace Non-Executive Director Andrew Nash as Chair of the Company's Remuneration Committee on appointment. Andrew will take over the role Senior Independent Director and will Chair MISSION's Audit and Risk Committee.

James Clifton, Chief Executive ofΒ TheΒ MISSION Group plc, commented:Β "We are very excited to have Dr Filby on board. She has unique specialist expertise on generational differences and trends, which is highly relevant and valuable to much of the work MISSION does for Clients seeking to better understand their consumers. As well as extensive experience advising blue-chip corporates and government bodies, Dr Filby is a regular speaker at major business events such as the Financial Times CEO Forum. A published author, Dr Filby has also led and authored several reports and projects into the future of workplace dynamics and demographic trends."

Β 

Dr Eliza Filby added: "I am thrilled to be joining The MISSION Group and working with James and the team. It is a fantastic business and I look forward to supporting it through its future growth journey."

Β 

ENQUIRIES:

James Clifton, Chief Executive Officer

GilesΒ Lee, Chief Financial Officer

TheΒ MISSIONΒ Group plc

Β 

Β 

020 7462 1415

Β 

Β 

Mark PercyΒ /Β James ThomasΒ /Β Fiona Conroy

Shore Capital (Nomad and Broker)

020 7408 4090

Β 

Β 

Β 

Kate HoareΒ /Β Laura Stewart

HOUSTONΒ (Financial PR and Investor Relations)

0204 529 0549

Β 

NOTES TO EDITORS

Β 

MISSIONΒ is a collective of Creative and MarTech Agencies led by entrepreneurs who encourage an independent spirit.Β Employing 1,000 people across 27 locations and 3 continents, the Group successfully combines its diverse expertise to produceΒ Work ThatΒ CountsΒ for our Clients, whatever their ambitions. Creating real standout, sharing real innovation and delivering real business growth for some of the world's biggest brands.Β www.themission.co.uk

Β 

Regulatory disclosuresΒ (in accordance with Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies)

Save for the information set out above and below, there are no further disclosures to be made in accordance with Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies in respect of the appointment of Dr Elizabeth Rosana Filby, aged 40.

Dr Filby holds the following current directorships

Eliza Filby Associates Ltd

Filbyproductions Ltd

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
BOAEQLFFFLLBFBL
Date   Source Headline
24th Sep 20217:30 amRNSHolding(s) in Company
23rd Sep 20216:10 pmRNSDirector/PDMR Shareholding
22nd Sep 20217:00 amRNSInterim Results for six months to 30 June 2021
14th Jul 20217:00 amRNSTRADING UPDATE AND NOTICE OF INTERIM RESULTS
28th Jun 20217:00 amRNSGrowth Share Scheme
25th Jun 20212:17 pmRNSHolding(s) in Company
15th Jun 20217:00 amRNSDirector/PDMR Shareholding
14th Jun 20211:38 pmRNSResult of AGM
14th Jun 20217:00 amRNSTR1: Notification of Major Holdings
11th May 20219:19 amRNSHolding(s) in Company
30th Apr 20217:00 amRNSDirectorate Changes
26th Apr 20215:05 pmRNSCorrection: Director/PDMR Shareholding
26th Apr 202112:15 pmRNSDirector/PDMR Shareholding
19th Apr 20216:04 pmRNSDirector/PDMR Shareholding
14th Apr 20217:01 amRNSFinal Results for the Year Ended 31 December 2020
14th Apr 20217:00 amRNSChanges to the Board
11th Mar 20214:40 pmRNSDirector/PDMR Shareholding
24th Feb 20217:00 amRNSHolding(s) in Company
22nd Feb 20215:37 pmRNSDirector/PDMR Shareholding
9th Feb 20219:24 amRNSDirector/PDMR Shareholding
25th Jan 20214:40 pmRNSSecond Price Monitoring Extn
25th Jan 20214:35 pmRNSPrice Monitoring Extension
20th Jan 20217:00 amRNSTrading Update and Notice of Results
11th Nov 20204:58 pmRNSHolding(s) in Company
23rd Sep 20207:00 amRNSInterim Results
27th Jul 20207:00 amRNSACQUISITION OF INNOVATIONBUBBLE
15th Jul 20207:00 amRNSTrading Statement and Notice of Interim Results
15th Jun 20203:37 pmRNSResult of AGM
21st May 20207:00 amRNSCovid-19 and AGM Update
11th May 20204:58 pmRNSDirector Dealing and Issue of Consideration Shares
17th Apr 20203:36 pmRNSIssue of Equity
7th Apr 20205:00 pmRNSPDMR Shareholding pursuant to Growth Share Scheme
1st Apr 20207:00 amRNSFinal Results for the year ended 31 December 2019
27th Mar 20205:22 pmRNSCOVID-19 UPDATE
25th Mar 202011:05 amRNSSecond Price Monitoring Extn
25th Mar 202011:00 amRNSPrice Monitoring Extension
13th Mar 20202:22 pmRNSHolding(s) in Company
22nd Jan 20207:00 amRNSTrading Update
9th Dec 201911:55 amRNSDirector/PDMR Shareholding
5th Dec 20197:00 amRNSLaunch of Global Competition
25th Sep 20197:00 amRNSChange of Name
25th Sep 20197:00 amRNSHalf-year Report
13th Aug 20197:00 amRNSEBT Share Dealings
7th Aug 20198:15 amRNSEBT Share Dealings
1st Aug 20191:11 pmRNSDirector/PDMR Shareholding - Replacement
1st Aug 20197:00 amRNSDirector/PDMR Shareholding
15th Jul 20197:00 amRNSTrading Update
17th Jun 201912:57 pmRNSResult of AGM
17th Jun 201911:58 amRNSBoard Changes
12th Jun 20195:26 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.